Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug. This report contains market size and forecasts of Platinum based Cancer Drug in global, including the following market information:
Global Platinum based Cancer Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Platinum based Cancer Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Platinum based Cancer Drug companies in 2022 (%)
The global Platinum based Cancer Drug market was valued at US$ 1586.5 million in 2022 and is projected to reach US$ 1896.7 million by 2029, at a CAGR of 2.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
We surveyed the Platinum based Cancer Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Platinum based Cancer Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum based Cancer Drug Market Segment Percentages, by Type, 2022 (%)
Cisplatin
Oxaliplatin
Carboplatin
Others
Global Platinum based Cancer Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum based Cancer Drug Market Segment Percentages, by Application, 2022 (%)
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Global Platinum based Cancer Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum based Cancer Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platinum based Cancer Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Platinum based Cancer Drug revenues share in global market, 2022 (%)
Key companies Platinum based Cancer Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Platinum based Cancer Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Platinum based Cancer Drug, market overview.
Chapter 2: Global Platinum based Cancer Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Platinum based Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Platinum based Cancer Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Platinum based Cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Platinum based Cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Platinum based Cancer Drug Overall Market Size
2.1 Global Platinum based Cancer Drug Market Size: 2022 VS 2029
2.2 Global Platinum based Cancer Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Platinum based Cancer Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Platinum based Cancer Drug Players in Global Market
3.2 Top Global Platinum based Cancer Drug Companies Ranked by Revenue
3.3 Global Platinum based Cancer Drug Revenue by Companies
3.4 Global Platinum based Cancer Drug Sales by Companies
3.5 Global Platinum based Cancer Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Platinum based Cancer Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Platinum based Cancer Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Platinum based Cancer Drug Players in Global Market
3.8.1 List of Global Tier 1 Platinum based Cancer Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Platinum based Cancer Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Platinum based Cancer Drug Market Size Markets, 2022 & 2029
4.1.2 Cisplatin
4.1.3 Oxaliplatin
4.1.4 Carboplatin
4.1.5 Others
4.2 By Type - Global Platinum based Cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Platinum based Cancer Drug Revenue, 2018-2023
4.2.2 By Type - Global Platinum based Cancer Drug Revenue, 2024-2029
4.2.3 By Type - Global Platinum based Cancer Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Platinum based Cancer Drug Sales & Forecasts
4.3.1 By Type - Global Platinum based Cancer Drug Sales, 2018-2023
4.3.2 By Type - Global Platinum based Cancer Drug Sales, 2024-2029
4.3.3 By Type - Global Platinum based Cancer Drug Sales Market Share, 2018-2029
4.4 By Type - Global Platinum based Cancer Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Platinum based Cancer Drug Market Size, 2022 & 2029
5.1.2 Colorectal Cancer
5.1.3 Ovarian Cancer
5.1.4 Lung Cancer
5.1.5 Others
5.2 By Application - Global Platinum based Cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Platinum based Cancer Drug Revenue, 2018-2023
5.2.2 By Application - Global Platinum based Cancer Drug Revenue, 2024-2029
5.2.3 By Application - Global Platinum based Cancer Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Platinum based Cancer Drug Sales & Forecasts
5.3.1 By Application - Global Platinum based Cancer Drug Sales, 2018-2023
5.3.2 By Application - Global Platinum based Cancer Drug Sales, 2024-2029
5.3.3 By Application - Global Platinum based Cancer Drug Sales Market Share, 2018-2029
5.4 By Application - Global Platinum based Cancer Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Platinum based Cancer Drug Market Size, 2022 & 2029
6.2 By Region - Global Platinum based Cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Platinum based Cancer Drug Revenue, 2018-2023
6.2.2 By Region - Global Platinum based Cancer Drug Revenue, 2024-2029
6.2.3 By Region - Global Platinum based Cancer Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Platinum based Cancer Drug Sales & Forecasts
6.3.1 By Region - Global Platinum based Cancer Drug Sales, 2018-2023
6.3.2 By Region - Global Platinum based Cancer Drug Sales, 2024-2029
6.3.3 By Region - Global Platinum based Cancer Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Platinum based Cancer Drug Revenue, 2018-2029
6.4.2 By Country - North America Platinum based Cancer Drug Sales, 2018-2029
6.4.3 US Platinum based Cancer Drug Market Size, 2018-2029
6.4.4 Canada Platinum based Cancer Drug Market Size, 2018-2029
6.4.5 Mexico Platinum based Cancer Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Platinum based Cancer Drug Revenue, 2018-2029
6.5.2 By Country - Europe Platinum based Cancer Drug Sales, 2018-2029
6.5.3 Germany Platinum based Cancer Drug Market Size, 2018-2029
6.5.4 France Platinum based Cancer Drug Market Size, 2018-2029
6.5.5 U.K. Platinum based Cancer Drug Market Size, 2018-2029
6.5.6 Italy Platinum based Cancer Drug Market Size, 2018-2029
6.5.7 Russia Platinum based Cancer Drug Market Size, 2018-2029
6.5.8 Nordic Countries Platinum based Cancer Drug Market Size, 2018-2029
6.5.9 Benelux Platinum based Cancer Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Platinum based Cancer Drug Revenue, 2018-2029
6.6.2 By Region - Asia Platinum based Cancer Drug Sales, 2018-2029
6.6.3 China Platinum based Cancer Drug Market Size, 2018-2029
6.6.4 Japan Platinum based Cancer Drug Market Size, 2018-2029
6.6.5 South Korea Platinum based Cancer Drug Market Size, 2018-2029
6.6.6 Southeast Asia Platinum based Cancer Drug Market Size, 2018-2029
6.6.7 India Platinum based Cancer Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Platinum based Cancer Drug Revenue, 2018-2029
6.7.2 By Country - South America Platinum based Cancer Drug Sales, 2018-2029
6.7.3 Brazil Platinum based Cancer Drug Market Size, 2018-2029
6.7.4 Argentina Platinum based Cancer Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Platinum based Cancer Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Platinum based Cancer Drug Sales, 2018-2029
6.8.3 Turkey Platinum based Cancer Drug Market Size, 2018-2029
6.8.4 Israel Platinum based Cancer Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Platinum based Cancer Drug Market Size, 2018-2029
6.8.6 UAE Platinum based Cancer Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Platinum based Cancer Drug Major Product Offerings
7.1.4 Sanofi Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Hengrui Medicine
7.2.1 Hengrui Medicine Company Summary
7.2.2 Hengrui Medicine Business Overview
7.2.3 Hengrui Medicine Platinum based Cancer Drug Major Product Offerings
7.2.4 Hengrui Medicine Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.2.5 Hengrui Medicine Key News & Latest Developments
7.3 ASK Pharma
7.3.1 ASK Pharma Company Summary
7.3.2 ASK Pharma Business Overview
7.3.3 ASK Pharma Platinum based Cancer Drug Major Product Offerings
7.3.4 ASK Pharma Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.3.5 ASK Pharma Key News & Latest Developments
7.4 Yi Bai Pharmaceutical
7.4.1 Yi Bai Pharmaceutical Company Summary
7.4.2 Yi Bai Pharmaceutical Business Overview
7.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Major Product Offerings
7.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.4.5 Yi Bai Pharmaceutical Key News & Latest Developments
7.5 Qilu Pharmaceutical
7.5.1 Qilu Pharmaceutical Company Summary
7.5.2 Qilu Pharmaceutical Business Overview
7.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Major Product Offerings
7.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.5.5 Qilu Pharmaceutical Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Platinum based Cancer Drug Major Product Offerings
7.6.4 Teva Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Platinum based Cancer Drug Major Product Offerings
7.7.4 Pfizer Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Dr Reddy's Laboratories
7.8.1 Dr Reddy's Laboratories Company Summary
7.8.2 Dr Reddy's Laboratories Business Overview
7.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Major Product Offerings
7.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.8.5 Dr Reddy's Laboratories Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Platinum based Cancer Drug Major Product Offerings
7.9.4 Mylan Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Sun Pharma
7.10.1 Sun Pharma Company Summary
7.10.2 Sun Pharma Business Overview
7.10.3 Sun Pharma Platinum based Cancer Drug Major Product Offerings
7.10.4 Sun Pharma Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.10.5 Sun Pharma Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Platinum based Cancer Drug Business Overview
7.11.3 Novartis Platinum based Cancer Drug Major Product Offerings
7.11.4 Novartis Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.11.5 Novartis Key News & Latest Developments
7.12 Debiopharm
7.12.1 Debiopharm Company Summary
7.12.2 Debiopharm Platinum based Cancer Drug Business Overview
7.12.3 Debiopharm Platinum based Cancer Drug Major Product Offerings
7.12.4 Debiopharm Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.12.5 Debiopharm Key News & Latest Developments
7.13 Accord Healthcare
7.13.1 Accord Healthcare Company Summary
7.13.2 Accord Healthcare Platinum based Cancer Drug Business Overview
7.13.3 Accord Healthcare Platinum based Cancer Drug Major Product Offerings
7.13.4 Accord Healthcare Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.13.5 Accord Healthcare Key News & Latest Developments
7.14 SK Chemicals
7.14.1 SK Chemicals Company Summary
7.14.2 SK Chemicals Business Overview
7.14.3 SK Chemicals Platinum based Cancer Drug Major Product Offerings
7.14.4 SK Chemicals Platinum based Cancer Drug Sales and Revenue in Global (2018-2023)
7.14.5 SK Chemicals Key News & Latest Developments
8 Global Platinum based Cancer Drug Production Capacity, Analysis
8.1 Global Platinum based Cancer Drug Production Capacity, 2018-2029
8.2 Platinum based Cancer Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Platinum based Cancer Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Platinum based Cancer Drug Supply Chain Analysis
10.1 Platinum based Cancer Drug Industry Value Chain
10.2 Platinum based Cancer Drug Upstream Market
10.3 Platinum based Cancer Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Platinum based Cancer Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Platinum based Cancer Drug in Global Market
Table 2. Top Platinum based Cancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Platinum based Cancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Platinum based Cancer Drug Revenue Share by Companies, 2018-2023
Table 5. Global Platinum based Cancer Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Platinum based Cancer Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Platinum based Cancer Drug Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Platinum based Cancer Drug Product Type
Table 9. List of Global Tier 1 Platinum based Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Platinum based Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Platinum based Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Platinum based Cancer Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Platinum based Cancer Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Platinum based Cancer Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Platinum based Cancer Drug Sales (K Units), 2024-2029
Table 16. By Application ? Global Platinum based Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Platinum based Cancer Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Platinum based Cancer Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Platinum based Cancer Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Platinum based Cancer Drug Sales (K Units), 2024-2029
Table 21. By Region ? Global Platinum based Cancer Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Platinum based Cancer Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Platinum based Cancer Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Platinum based Cancer Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Platinum based Cancer Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Platinum based Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Platinum based Cancer Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Platinum based Cancer Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Platinum based Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Platinum based Cancer Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Platinum based Cancer Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Platinum based Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Platinum based Cancer Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Platinum based Cancer Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Platinum based Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Platinum based Cancer Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Platinum based Cancer Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Platinum based Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Platinum based Cancer Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Platinum based Cancer Drug Sales, (K Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Platinum based Cancer Drug Product Offerings
Table 48. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Hengrui Medicine Company Summary
Table 51. Hengrui Medicine Platinum based Cancer Drug Product Offerings
Table 52. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Hengrui Medicine Key News & Latest Developments
Table 54. ASK Pharma Company Summary
Table 55. ASK Pharma Platinum based Cancer Drug Product Offerings
Table 56. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. ASK Pharma Key News & Latest Developments
Table 58. Yi Bai Pharmaceutical Company Summary
Table 59. Yi Bai Pharmaceutical Platinum based Cancer Drug Product Offerings
Table 60. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Yi Bai Pharmaceutical Key News & Latest Developments
Table 62. Qilu Pharmaceutical Company Summary
Table 63. Qilu Pharmaceutical Platinum based Cancer Drug Product Offerings
Table 64. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Qilu Pharmaceutical Key News & Latest Developments
Table 66. Teva Company Summary
Table 67. Teva Platinum based Cancer Drug Product Offerings
Table 68. Teva Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Teva Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Platinum based Cancer Drug Product Offerings
Table 72. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Dr Reddy's Laboratories Company Summary
Table 75. Dr Reddy's Laboratories Platinum based Cancer Drug Product Offerings
Table 76. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Dr Reddy's Laboratories Key News & Latest Developments
Table 78. Mylan Company Summary
Table 79. Mylan Platinum based Cancer Drug Product Offerings
Table 80. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Mylan Key News & Latest Developments
Table 82. Sun Pharma Company Summary
Table 83. Sun Pharma Platinum based Cancer Drug Product Offerings
Table 84. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Sun Pharma Key News & Latest Developments
Table 86. Novartis Company Summary
Table 87. Novartis Platinum based Cancer Drug Product Offerings
Table 88. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Novartis Key News & Latest Developments
Table 90. Debiopharm Company Summary
Table 91. Debiopharm Platinum based Cancer Drug Product Offerings
Table 92. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Debiopharm Key News & Latest Developments
Table 94. Accord Healthcare Company Summary
Table 95. Accord Healthcare Platinum based Cancer Drug Product Offerings
Table 96. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Accord Healthcare Key News & Latest Developments
Table 98. SK Chemicals Company Summary
Table 99. SK Chemicals Platinum based Cancer Drug Product Offerings
Table 100. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. SK Chemicals Key News & Latest Developments
Table 102. Platinum based Cancer Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Platinum based Cancer Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Platinum based Cancer Drug Production by Region, 2018-2023 (K Units)
Table 105. Global Platinum based Cancer Drug Production by Region, 2024-2029 (K Units)
Table 106. Platinum based Cancer Drug Market Opportunities & Trends in Global Market
Table 107. Platinum based Cancer Drug Market Drivers in Global Market
Table 108. Platinum based Cancer Drug Market Restraints in Global Market
Table 109. Platinum based Cancer Drug Raw Materials
Table 110. Platinum based Cancer Drug Raw Materials Suppliers in Global Market
Table 111. Typical Platinum based Cancer Drug Downstream
Table 112. Platinum based Cancer Drug Downstream Clients in Global Market
Table 113. Platinum based Cancer Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Platinum based Cancer Drug Segment by Type in 2022
Figure 2. Platinum based Cancer Drug Segment by Application in 2022
Figure 3. Global Platinum based Cancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Platinum based Cancer Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Platinum based Cancer Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Platinum based Cancer Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Platinum based Cancer Drug Revenue in 2022
Figure 9. By Type - Global Platinum based Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Platinum based Cancer Drug Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Platinum based Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Platinum based Cancer Drug Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Platinum based Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Platinum based Cancer Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 23. US Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 28. Germany Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 37. China Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 44. Brazil Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Platinum based Cancer Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Platinum based Cancer Drug Sales Market Share, 2018-2029
Figure 48. Turkey Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Platinum based Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Platinum based Cancer Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Platinum based Cancer Drug by Region, 2022 VS 2029
Figure 54. Platinum based Cancer Drug Industry Value Chain
Figure 55. Marketing Channels
